Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesO12-D3-I3 is an ionizable cationic lipid (pKa = 6.39) that has been used in the generation of lipid nanoparticles (LNPs) for siRNA delivery in vitro and in vivo.1 LNPs containing O12-D3-I3 and encapsulating ferrocene and siRNA targeting nuclear factor erythroid 2-related factor 2 (Nrf2) or the system xc- cystine/glutamate transporter decrease viability of HepG2 hepatocellular carcinoma cells. LNPs containing O12-D3-I3 and an mRNA reporter selectively accumulate in the tumor and liver over the lungs, kidneys, spleen, and heart in an MCF-7 breast cancer mouse xenograft model. LNPs containing O12-D3-I3 and encapsulating ferrocene and either Nrf2-targeting siRNA or system xc- cystine/glutamate transporter-targeting siRNA reduce tumor growth and volume in an MCF-7 mouse xenograft model. LNPs containing O12-D3-I3 and encapsulating siRNA targeting Factor VII decrease hepatocyte Factor VII mRNA levels in mice.
WARNING This product is not for human or veterinary use.
1. Imidazolyl lipids enhanced LNP endosomal escape for ferroptosis RNAi treatment of cancer. Small 20(40), e2402362 (2024).